{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T01:07:12Z","timestamp":1779152832453,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-026-00557-4","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T06:55:29Z","timestamp":1776063329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distribution of Abnormal Hemoglobins in Saudi Arabia: Analysis of Private Sector Laboratory Data"],"prefix":"10.1007","volume":"16","author":[{"given":"Omar M.","family":"Raslan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman O.","family":"Radhwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadia B.","family":"Al Mahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman M.","family":"Mansory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"31\u201332","key":"557_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3238\/arztebl.2011.0532","volume":"108","author":"E -Kohne","year":"2011","unstructured":"-Kohne E. Hemoglobinopathies: clinical manifestations, diagnosis, and treatment. Dtsch Arztebl Int. 2011;108(31\u201332):532\u201340. https:\/\/doi.org\/10.3238\/arztebl.2011.0532.","journal-title":"Dtsch Arztebl Int"},{"key":"557_CR2","doi-asserted-by":"publisher","unstructured":"-GBD. 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585-e599. https:\/\/doi.org\/10.1016\/S2352-3026(23)00118-7","DOI":"10.1016\/S2352-3026(23)00118-7"},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"102619","DOI":"10.1016\/j.eclinm.2024.102619","volume":"72","author":"Y -Tuo","year":"2024","unstructured":"-Tuo Y, Li Y, Li Y, Ma J, Yang X, Wu S, Jin J, He Z. Global, regional, and national burden of thalassemia, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. EClinicalMedicine. 2024;72:102619. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102619.","journal-title":"EClinicalMedicine"},{"issue":"Suppl 1","key":"557_CR4","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jegh.2017.12.001","volume":"7","author":"ES -Alsaeed","year":"2018","unstructured":"-Alsaeed ES, Farhat GN, Assiri AM, Memish Z, Ahmed EM, Saeedi MY, Al-Dossary MF, Bashawri H. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011\u20132015. J Epidemiol Glob Health. 2018;7(Suppl 1):S41\u20137. https:\/\/doi.org\/10.1016\/j.jegh.2017.12.001.","journal-title":"J Epidemiol Glob Health"},{"issue":"3","key":"557_CR5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1182\/bloodadvances.2021006281","volume":"7","author":"KM -Johnson","year":"2023","unstructured":"-Johnson KM, Jiao B, Ramsey SD, Bender MA, Devine B, Basu A. Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Adv. 2023;7(3):365\u201374. https:\/\/doi.org\/10.1182\/bloodadvances.2021006281.","journal-title":"Blood Adv"},{"issue":"27","key":"557_CR6","doi-asserted-by":"publisher","first-page":"e43238","DOI":"10.1097\/MD.0000000000043238","volume":"104","author":"OO -Radhwi","year":"2025","unstructured":"-Radhwi OO, Alshehri A, Alajlani B, Mansory EM. The direct costs of transfusion-dependent beta-thalassemia in Saudi Arabia: A cost of illness analysis study. Med (Baltim). 2025;104(27):e43238. https:\/\/doi.org\/10.1097\/MD.0000000000043238.","journal-title":"Med (Baltim)"},{"issue":"2","key":"557_CR7","doi-asserted-by":"publisher","first-page":"a011775","DOI":"10.1101\/cshperspect.a011775","volume":"3","author":"A -Cao","year":"2013","unstructured":"-Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775. https:\/\/doi.org\/10.1101\/cshperspect.a011775.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"557_CR8","unstructured":"-Diagnostics AB, Al Borg D. 2024. Available from: https:\/\/alborgdx.com\/ksa\/en\/our-branches [last accessed October 4, 2025]."},{"key":"557_CR9","doi-asserted-by":"crossref","unstructured":"Bain -BJ, Rees DC. Haemoglobinopathy Diagnosis, (John Wiley & Sons, 2025).","DOI":"10.1002\/9781394265381"},{"issue":"3","key":"557_CR10","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s44197-024-00281-x","volume":"14","author":"M -Aljabry","year":"2024","unstructured":"-Aljabry M, Sulimani S, Alotaibi G, Aljabri H, Alomary S, Aljabri O, Sallam M, Alsultan A. Prevalence and regional distribution of beta-hemoglobin variants in Saudi Arabia: Insights from the national premarital screening program. J Epidemiol Glob Health. 2024;14(3):1242\u20138. https:\/\/doi.org\/10.1007\/s44197-024-00281-x.","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"557_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1751-553X.2011.01368.x","volume":"34","author":"AD -Stephens","year":"2012","unstructured":"-Stephens AD, Angastiniotis M, Baysal E, Chan V, Fucharoen S, Giordano PC, Hoyer JD, Mosca A, Wild B. International council for the standardisation of haematology (ICSH). ICSH recommendations for the measurement of haemoglobin A2. Int J Lab Hematol. 2012;34(1):1\u201313. https:\/\/doi.org\/10.1111\/j.1751-553X.2011.01368.x.","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"557_CR12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/ijlh.12037","volume":"35","author":"PC -Giordano","year":"2013","unstructured":"-Giordano PC. Strategies for basic laboratory diagnostics of the hemoglobinopathies in multi-ethnic societies: interpretation of results and pitfalls. Int J Lab Hematol. 2013;35(5):465\u201379. https:\/\/doi.org\/10.1111\/ijlh.12037.","journal-title":"Int J Lab Hematol"},{"issue":"13","key":"557_CR13","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.3390\/ijms22137229","volume":"22","author":"F -Longo","year":"2021","unstructured":"-Longo F, Piolatto A, Ferrero GB, Piga A. Ineffective erythropoiesis in \u03b2-thalassaemia: Key steps and therapeutic options by drugs. Int J Mol Sci. 2021;22(13):7229. https:\/\/doi.org\/10.3390\/ijms22137229.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"557_CR14","doi-asserted-by":"publisher","first-page":"a011726","DOI":"10.1101\/cshperspect.a011726","volume":"2","author":"AW -Nienhuis","year":"2012","unstructured":"-Nienhuis AW, Nathan DG. Pathophysiology and clinical manifestations of the \u03b2-thalassemias. Cold Spring Harb Perspect Med. 2012;2(12):a011726. https:\/\/doi.org\/10.1101\/cshperspect.a011726.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"557_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0889-8588(18)30422-2","volume":"5","author":"JA -Bollekens","year":"1991","unstructured":"-Bollekens JA, Forget BG. Delta beta thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am. 1991;5(3):399\u2013422.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"557_CR16","doi-asserted-by":"publisher","first-page":"a011700","DOI":"10.1101\/cshperspect.a011700","volume":"3","author":"SL -Thein","year":"2013","unstructured":"-Thein SL. The molecular basis of \u03b2-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700. https:\/\/doi.org\/10.1101\/cshperspect.a011700.","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-026-00557-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00557-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00557-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:26:47Z","timestamp":1779150407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-026-00557-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1007\/s44197-026-00557-4","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Unit of Biomedical Ethics at Al Borg Diagnostic, approval number (No11\/24). This study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki. The requirement for informed consent was waived by the IRB of the Unit of Biomedical Ethics of Al Borg Diagnostics, owing to the retrospective nature of the study and the use of anonymized data. Patient confidentiality was maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors consent to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"60"}}